FDA failed to prioritize over 70,000 adverse event reports related to puberty-blocking drugs, raising concerns about regulatory oversight of these medications
Side effects from puberty blockers range from headaches to serious conditions like brain swelling and vision loss
Puberty blockers disrupt normal development, causing long-term harm to physical development and psychological health in children
The FDA's handling of puberty blockers demonstrates inconsistent regulatory standards and inadequate public warnings about significant risks
The safety of puberty blockers and other gender-affirming care has not been established, and parents should research risks before making decisions